These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27565084)

  • 1. Modified breast cancer model for preclinical immunotherapy studies.
    Katsuta E; DeMasi SC; Terracina KP; Spiegel S; Phan GQ; Bear HD; Takabe K
    J Surg Res; 2016 Aug; 204(2):467-474. PubMed ID: 27565084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved syngeneic orthotopic murine model of human breast cancer progression.
    Rashid OM; Nagahashi M; Ramachandran S; Dumur C; Schaum J; Yamada A; Terracina KP; Milstien S; Spiegel S; Takabe K
    Breast Cancer Res Treat; 2014 Oct; 147(3):501-12. PubMed ID: 25200444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
    Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.
    Jiang YJ; Lee CL; Wang Q; Zhou ZW; Yang F; Jin C; Fu DL
    World J Gastroenterol; 2014 Jul; 20(28):9476-85. PubMed ID: 25071342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine breast cancer mastectomy model that predicts patient outcomes for drug development.
    Katsuta E; Rashid OM; Takabe K
    J Surg Res; 2017 Nov; 219():310-318. PubMed ID: 29078898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a metastatic murine colon cancer model.
    Terracina KP; Aoyagi T; Huang WC; Nagahashi M; Yamada A; Aoki K; Takabe K
    J Surg Res; 2015 Nov; 199(1):106-14. PubMed ID: 26009494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals.
    Coveney E; Clary B; Iacobucci M; Philip R; Lyerly K
    Surgery; 1996 Aug; 120(2):265-72; discussion 272-3. PubMed ID: 8751592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling and integral X-ray, optical, and MRI visualization of multiorgan metastases of orthotopic 4T1 breast carcinoma in BALB/c mice.
    Baklaushev VP; Grinenko NF; Yusubalieva GM; Abakumov MA; Gubskii IL; Cherepanov SA; Kashparov IA; Burenkov MS; Rabinovich EZ; Ivanova NV; Antonova OM; Chekhonin VP
    Bull Exp Biol Med; 2015 Feb; 158(4):581-8. PubMed ID: 25705045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden.
    Rashid OM; Nagahashi M; Ramachandran S; Graham L; Yamada A; Spiegel S; Bear HD; Takabe K
    Surgery; 2013 Jun; 153(6):771-8. PubMed ID: 23489938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model.
    Gregório AC; Fonseca NA; Moura V; Lacerda M; Figueiredo P; Simões S; Dias S; Moreira JN
    PLoS One; 2016; 11(11):e0165817. PubMed ID: 27820870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.
    Blazejczyk A; Switalska M; Chlopicki S; Marcinek A; Gebicki J; Nowak M; Nasulewicz-Goldeman A; Wietrzyk J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):110. PubMed ID: 27412454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation.
    Takahashi K; Nagai N; Ogura K; Tsuneyama K; Saiki I; Irimura T; Hayakawa Y
    Cancer Sci; 2015 Jul; 106(7):867-74. PubMed ID: 25940224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer.
    Zhang Y; Zhang N; Hoffman RM; Zhao M
    Anticancer Res; 2015 Sep; 35(9):4641-6. PubMed ID: 26254353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancer.
    Jahangiri S; Abtahi Froushani SM; Delirezh N
    Turk J Med Sci; 2016 Feb; 46(2):518-23. PubMed ID: 27511520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
    Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
    Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.